Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | |
|---|---|---|---|---|---|
| Sales | 186.30 | 217.40 | 199.84 | 182.74 | 222.97 |
| Operating profit | 0.80 | 4.20 | 2.18 | -1.89 | 7.30 |
| Interest | 7.10 | 6.40 | 5.70 | 5.53 | 4.14 |
| Gross profit | 12.10 | 13.70 | 10.14 | 0.45 | 109.28 |
| EPS (Rs) | -0.03 | 0.12 | -1.94 | -0.37 | 5.76 |
Quarterly
results in details
| Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | |
|---|---|---|---|---|---|
| Other income | 18.40 | 15.90 | 13.66 | 7.87 | 106.12 |
| Stock adjustment | -10.30 | 31.20 | 12.58 | -41.85 | 8.75 |
| Raw material | 94.90 | 71.90 | 90.39 | 116.65 | 100.92 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 46.10 | 47.50 | 40.07 | 42.91 | 43.73 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 54.80 | 62.60 | 54.62 | 66.92 | 62.27 |
| Provisions made | - | - | - | - | - |
| Depreciation | 11.90 | 11.40 | 11.37 | 11.59 | 11.08 |
| Taxation | 0.60 | 0.40 | 29.63 | -5.25 | 6.39 |
| Net profit / loss | -0.40 | 1.90 | -30.86 | -5.89 | 91.81 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.90 | 15.90 | 15.93 | 15.93 | 15.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 0.43 | 1.93 | 1.09 | -1.03 | 3.27 |
| GPM (%) | 5.91 | 5.87 | 4.75 | .24 | 33.21 |
| NPM (%) | -0.20 | 0.81 | -14.45 | -3.09 | 27.90 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis